More News

11 Apr 2007 Inhibitex Signs Definitive Agreement to Acquire FermaVir Pharmaceuticals
10 Apr 2007 Caliper Life Sciences to Explore Novel Indications for Drug Candidates
07 Apr 2007 Stratagene Signs Definitive Agreement to Be Acquired by Agilent Technologies
06 Apr 2007 JDRF To Collaborate with MediGene to Develop an Antigen-Specific Immunotherapeutic for Type I Diabetes
05 Apr 2007 pSivida signs A$203 million (US$165 million)
05 Apr 2007 pSivida signs A$203 million (US$165 million)
05 Apr 2007 AVEO enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO's Novel Anti-HGF Antibody
05 Apr 2007 Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
05 Apr 2007 CytoGenix Announces Successful Testing of synDNA(TM) Vaccine for Avian Influenza Virus
05 Apr 2007 Boca Pharmacal Receives FDA Approval for Generic Pamine(R) and Pamine(R) Forte Tablets
04 Apr 2007 Pharmexa and Affitech enter into an exclusive license agreement to promote Diabody technology
04 Apr 2007 IMPAX Announces FDA Approval of Generic Corzide
03 Apr 2007 Roche acquires THP to expand its therapeutic antibody research
03 Apr 2007 Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show
03 Apr 2007 Senetek PLC Grants Paid Up License to Valeant Pharmaceuticals
03 Apr 2007 CSL Biotherapies Submits BLA to Introduce Flu Vaccine to U.S. Market
31 Mar 2007 Astellas Licenses RegeneronĀ“s Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
31 Mar 2007 Takeda to Obtain Development and Commercial Rights
31 Mar 2007 CanBas and Takeda to Sign the Collaboration Agreement
31 Mar 2007 LG Life Sciences and Takeda Announce Collaboration
30 Mar 2007 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
30 Mar 2007 Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
30 Mar 2007 Ad hoc: Evotec to Acquire Neuro3d
29 Mar 2007 Oxford BioMedica and Sanofi-Aventis Enter Global Licensing Agreement to Develop and Commercialise TroVax for Cancer
29 Mar 2007 MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's Third Japanese Pharmaceutical Alliance

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top